Arvind Srivastava, based in New York, NY, US, is currently a Technical Fellow, Research and Development at Avantor, bringing experience from previous roles at Avantor, Eli Lilly and Company and ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company. Arvind Srivastava holds a Postdoc in Biochemistry @ University of North Carolina at Chapel Hill. With a robust skill set that includes Biotechnology, 21 CFR Part 11, Antibodies, Biochemistry, Biopharmaceuticals and more, Arvind Srivastava contributes valuable insights to the industry. Arvind Srivastava has 3 emails on RocketReach.